Cardiol Therapeutics (OTCMKTS:CRTPF) Shares Down 1.6% – What’s Next?
by Jessica Moore · The Cerbat GemCardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s stock price fell 1.6% on Wednesday . The stock traded as low as $1.18 and last traded at $1.21. 1,416,014 shares traded hands during trading, an increase of 2,010% from the average daily volume of 67,097 shares. The stock had previously closed at $1.23.
Cardiol Therapeutics Stock Down 1.6%
The stock has a 50 day simple moving average of $1.13 and a 200-day simple moving average of $1.14.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.